Institutional Ownership
Estrella Immunopharma Inc
CUSIP 297584104COMESLAQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
71.8%
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Oct 30, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 30, 2023 | Eureka Therapeutics, Inc. | 13D | 71.8% | 25.28M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 4.10M | $4.34M |
| 2 | Wells Fargo & Company/Mn | 264.4K | $280.3K |
| 3 | Geode Capital Management, LLC | 157.5K | $166.9K |
| 4 | Renaissance Technologies LLC | 62.8K | $66.6K |
| 5 | State Street Corp | 43.3K | $45.8K |
| 6 | Blackrock, Inc. | 39.9K | $42.3K |
| 7 | Northern Trust Corp | 19.6K | $20.8K |
| 8 | Us Bancorp \De\ | 16.9K | $17.9K |
| 9 | Ubs Group AG | 15.1K | $16.0K |
| 10 | Royal Bank Of Canada | 6.6K | $7.0K |